Medi-Tech Insights Research Reports

The  Medical device 3D printing market  is poised to revolutionize the global healthcare industry. It is being increasingly used in medical and dental market for prototyping; producing anatomic models for surgical planning; making surgical guides; and manufacture of implants, instruments and prosthetics. Growing preference for medical device 3D printing over traditional machining methods owing to advantages such as less wastage of materials, cost effectiveness for smaller batches/more complex shapes and better clinical outcomes is driving the medical device 3D printing market growth. Moreover, the rising aging population, steady growth in Orthopaedics and dental procedures, and improving reimbursement scenario are other important factors driving the medical 3D printing market growth. In terms of opportunities, underpenetrated applications such as regenerative medicine and point of care 3D printing are likely to be the high growth areas of the medical 3D printing market in the upcoming

Single-use bioreactors are bioreactors that use the disposable bag as a substitute for a culture vessel made of stainless steel or glass. It is widely used by pharmaceutical companies for cell harvesting, media & buffer preparation, filtration, purification, and virus inactivation. Due to their Ability to Enhance Flexibility, Reduce Investment & Limit Operational Costs, Single-use Bioreactors Have Become Established in Modern Biopharmaceutical Processes Enhanced flexibility is one of the biggest benefits of single-use bioreactors. There is a growing trend towards multi-drug facilities, which warrants the production of different drugs using the same facility with minimum time & cost and top-notch quality. In such scenarios, one of the key manufacturing challenges is line clearance and validation of cleaning to ensure there is no carry-over from earlier batches. Downtime limits the number of batches produced in a given period. Single-use bioreactors significantly reduce the t

The global Vaccine CDMO market is driven by increased demand from biotech vaccine developers & more selective outsourcing by pharmaceutical companies.   Vaccine manufacturing is a highly complex process compared to small molecules. Currently, the penetration of CDMO is less than 20% of overall manufacturing value with ample opportunity for growth. There is growing trend towards outsourcing by the pharma and biotech industry for vaccine development and manufacturing. While biotech companies largely lack internal capabilities on process development and in-house manufacturing facilities qualified with GMP or BSL1 or BSL2 levels; big pharma companies mainly approach CDMOs for high volume vaccine manufacturing, risk mitigation and fill and finish activities. Also, large pharma may struggle to meet rising demand for new technology vaccines like viral vector and mRNA. Moreover, increased interest in development of newer vaccines like shingles, RSV, infectious diseases by smaller biotech

Omics has turned out to be a new mantra in molecular research. It is a field of study in biological sciences that ends in the suffix – omics. Many areas of research can be classified as omics such as genomics, transcriptomics, proteomics and metabolomics. ·         Genomics studies genes and their function. Genomics finds application in drug discovery and development, diagnostics & therapeutic decision-making, agriculture, animal research and other applications. ·         Transcriptomics studies mRNAs. It is widely used for clinical diagnostics, drug discovery, toxicogenomics and other applications. ·         Proteomics studies proteins. It is used for clinical diagnosis of cancer, infectious diseases, cardiovascular diseases, immune diseases, neurological disorders, diabetes, etc. and drug discovery. ·         Metabonomics studies small molecules involved in cellular metabolism. It is a powerful research tool that is currently being applied to various aspects of drug and b